The burden of allergic rhinitis

Allergy and Asthma Proceedings

Volumn 28, Issue 1, 2007, Pages 3-9

  Nathan, Robert A ^a,b,c  

^a UNIVERSITY OF COLORADO   (United States)

^b Asthma and Allergy Associates and Research Center   (United States)

^c Asthma & Allergy Associates PC and Research Center   (United States)

Author keywords

Allergic rhinitis; Asthma; Nasal congestion; Sleep disorders

Indexed keywords

ANTIALLERGIC AGENT;

ABSENTEEISM; ARTICLE; COMORBIDITY; COST OF ILLNESS; DOCTOR PATIENT RELATION; ECONOMICS; HAY FEVER; HEALTH CARE COST; HUMAN; HUMAN RELATION; MOOD DISORDER; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PATIENT SATISFACTION; PERENNIAL RHINITIS; PHYSICIAN ATTITUDE; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; SLEEP DISORDER; TREATMENT OUTCOME;

ABSENTEEISM; ANTI-ALLERGIC AGENTS; COMORBIDITY; COST OF ILLNESS; HEALTH CARE COSTS; HUMANS; INTERPERSONAL RELATIONS; MOOD DISORDERS; PATIENT COMPLIANCE; PATIENT SATISFACTION; PHYSICIAN'S ROLE; PHYSICIAN-PATIENT RELATIONS; QUALITY OF LIFE; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; SLEEP DISORDERS; TREATMENT OUTCOME;

EID: 33847607537     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: 10.2500/aap.2007.28.2934     Document Type: Article

References (47)

1. HealthStar Communications, Inc., in partnership with Schulman, Ronca and Bucuvalas, Inc. Allergies in America: A Landmark Survey of Nasal Allergy Sufferers. Executive Summary. Florham Park, NJ: Altana Pharma US, Inc., 2006.
2. Schoenwetter WF, Dupclay L Jr, Appajosyula S, et al. Economic impact and quality-of-life burden of allergic rhinitis. Curr Med Res Opin 20:305-317, 2004.
3. Nathan RA, Meltzer EO, Seiner JC, et al. Prevalence of allergic rhinitis in the United States. J Allergy Clin Immunol 99:S808-S814, 1997.
4. Derebery JM, Boyle JM, and Droar J. Patient perspectives: AR and medication. Otolaryngol Head Neck Surg 135:P96, 2006.
5. Shedden A, and Iezzoni D. The impact of morning symptoms in allergic rhinitis: Findings from an online survey. Ann Allergy Asthma Immunol 96:192, 2006 (Abs P120).
6. Casale TB, and Dykewicz MS. Clinical implications of the allergic rhinitis-asthma link. Am J Med Sci 327:127-138, 2004.
7. Leynaert B, Neukirch C, Liard R, et al. Quality of life in allergic rhinitis and asthma: A population-based study of young adults. Am J Respir Crit Care Med 162:1391-1396, 2000.
8. Nayak AS. The asthma and allergic rhinitis link. Allergy Asthma Proc 24:395-402, 2003.
9. Bousquet J, Bullinger M, Fayol C, et al. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol 94:182-188, 1994.
10. Bousquet J, Knani J, Dhivert H, et al. Quality of life in asthma: I. Internal consistency and validity of the SF-36 questionnaire. Am J Respir Crit Care Med 149:371-375, 1994.
11. Nathan RA. Burden of allergic rhinitis. Oral presentation at the Eastern Allergy Conference on Allergy, Asthma, and Immunology, May 4-7, 2006, Naples, Florida.
12. Young T, Finn L, and Kim H. Nasal obstruction as a risk factor for sleep-disordered breathing. The University of Wisconsin Sleep and Respiratory Research Group. J Allergy Clin Immunol 99:S757-S762, 1997.
13. Craig TJ, McCann JL, Gurevich F, et al. The correlation between allergic rhinitis and sleep disturbance. J Allergy Clin Immunol 114:S139-S145, 2004.
14. Golbin A, Bernales R, and Lim DT. Perennial allergic rhinitis (PAR), and sleep disorders. Ann Allergy 68:85, 1992 (Abs 60).
15. Juniper EF, Guyatt GH, and Dolovich J. Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: Development and testing of a questionnaire for clinical trials. J Allergy Clin Immunol 93:413-423, 1994.
16. Klossek JM, Gohler C, Vervloet D, et al. Epidemiology of seasonal spring-time allergic rhinitis in adults in France. Presse Med 34:348-352, 2005.
17. Lavie P, Gertner R, Zomer J, et al. Breathing disorders in sleep associated with "microarousals" in patients with allergic rhinitis. Acta Otolaryngol 92:529-533, 1981.
18. Stuck BA, Czajkowski J, Hagner AE, et al. Changes in daytime sleepiness, quality of life, and objective sleep patterns in seasonal allergic rhinitis: A controlled clinical trial. J Allergy Clin Immunol 113:663-668, 2004.
19. Chang PP, Ford DE, Mead LA, et al. Insomnia in young men and subsequent depression. The Johns Hopkins Precursors Study. Am J Epidemiol 146:105-114, 1997.
20. Breslau N, Roth T, Rosenthal L, et al. Sleep disturbance and psychiatric disorders: A longitudinal epidemiological study of young adults. Biol Psychiatry 39:411-418, 1996.
21. Owens J, Opipari L, Nobile C, et al. Sleep and daytime behavior in children with obstructive sleep apnea and behavioral sleep disorders. Pediatrics 102:1178-1184, 1998.
22. Gozal D. Sleep-disordered breathing and school performance in children. Pediatrics 102:616-620, 1998.
23. Vuurman EF, van Veggel LM, Uiterwijk MM, et al. Seasonal allergic rhinitis and antihistamine effects on children's learning. Ann Allergy 71:121-126, 1993.
24. Scadding GK, Richards DH, and Price MJ. Patient and physician perspectives on the impact and management of perennial and seasonal allergic rhinitis. Clin Otolaryngol Allied Sci 25:551-557, 2000.
25. Meltzer EO. Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol 108:545-553, 2001.
26. Tanner LA, Reilly M, Meltzer EO, et al. Effect of fexofenadine HCl on quality of life and work, classroom, and daily activity impairment in patients with seasonal allergic rhinitis. Am J Manag Care 5(suppl):S235-S247, 1999.
27. Dykewicz MS, Fineman S, Skoner DP, et al. Diagnosis and management of rhinitis: Complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology. Ann Allergy Asthma Immunol 81:478-518, 1998.
28. 1 receptor antagonists in allergic rhinitis: Systematic review of randomised controlled trials. BMJ 317: 1624-1629, 1998.
29. Naclerio RM, Boyle J, and Droar J. AR: Patient perspectives on INCS. Otolaryngol Head Neck Surg 135:P169 (Abs R184), 2006.
30. Spector SL. Overview of comorbid associations of allergic rhinitis. J Allergy Clin Immunol 99:5773-5780, 1997.
31. Welsh PW, Stricker WE, Chu CP, et al. Efficacy of beclomethasone nasal solution, flunisolide, and cromolyn in relieving symptoms of ragweed allergy. Mayo Clin Proc 62:125-134, 1987.
32. Watson WT, Becker AB, and Simons FE. Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: Effect on lower airway responsiveness. J Allergy Clin Immunol 91:97-101, 1993.
33. Foresi A, Pelucchi A, Gherson G, et al. Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis. J Allergy Clin Immunol 98:274-282, 1996.
34. Corren J, Adinoff AD, Buchmeier AD, et al. Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma. J Allergy Clin Immunol 90:250-256, 1992.
35. Crystal-Peters J, Neslusan C, Crown WH, et al. Treating allergic rhinitis in patients with comorbid asthma: The risk of asthma-related hospitalizations and emergency department visits. J Allergy Clin Immunol 109:57-62, 2002.
36. Bernstein JM, Lee J, Conboy K, et al. Further observations on the role of IgE-mediated hypersensitivity in recurrent otitis media with effusion. Otolaryngol Head Neck Surg 93:611-615, 1985.
37. Tomonaga K, Kurono Y, and Mogi G. The role of nasal allergy in otitis media with effusion. A clinical study. Acta Otolaryngol Suppl 458:41-47, 1988.
38. Bernstein JM. The role of IgE-mediated hypersensitivity in the development of otitis media with effusion. Otolaryngol Clin North Am 25:197-211, 1992.
39. Fasce L, Ciprandi G, Pronzato C, et al. Cetirizine reduces ICAM-I on epithelial cells during nasal minimal persistent inflammation in asymptomatic children with mite-allergic asthma. Int Arch Allergy Immunol 109:272-276, 1996.
40. Lemanske RF Jr, Dick EC, Swenson CA, et al. Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J Clin Invest 83:1-10, 1989.
41. Spector SL, Nicklas RA, Chapman JA, et al. Symptom severity assessment of allergic rhinitis: Part 1. Ann Allergy Asthma Immunol 91:105-114, 2003.
42. Goetzel RZ, Long SR, Ozminkowski RJ, et al. Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting U.S. employers. J Occup Environ Med 46:398-412, 2004.
43. Blaiss MS. Important aspects in management of allergic rhinitis: Compliance, cost, and quality of life. Allergy Asthma Proc 24:231-238, 2003.
44. Santos R, Cifaldi M, Gregory C, et al. Economic outcomes of a targeted intervention program: The costs of treating allergic rhinitis patients. Am J Manag Care 5(suppl):S225-S234, 1999.
45. Lamb CE, Ratner PH, Johnson CE, et al. Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective. Curr Med Res Opin 22:1203-1210, 2006.
46. Kay GG. The effects of antihistamines on cognition and performance. J Allergy Clin Immunol 105:S622-8627, 2000.
47. Hadley JA, Boyle JM, and Droar J. Physicians' views on AR and treatments. Otolaryngol Head and Neck Surg 135:P170 (Abs R188), 2006. D